Japan is at risk of undermining its drug discovery goals

Additional reforms are needed or recent efforts will have been in vain

20241220 MHLW japan

Japan's positive efforts to invigorate its innovative drug market were highlighted when former Prime Minister Fumio Kishida this summer hosted an event that emphasized the government's renewed focus on pharmaceutical innovation.

Kurt Tong is managing partner at The Asia Group and a former senior U.S. diplomat who served in Japan and other Asian economies. Alexandra Melillo is an associate vice president at The Asia Group.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.